Biosynthetic Modularity Rules in the Bisintercalator Family of Antitumor Compounds
AbstractDiverse actinomycetes produce a family of structurally and biosynthetically related non-ribosomal peptide compounds which belong to the chromodepsipeptide family. These compounds act as bisintercalators into the DNA helix. They give rise to antitumor, antiparasitic, antibacterial and antiviral bioactivities. These compounds show a high degree of conserved modularity (chromophores, number and type of amino acids). This modularity and their high sequence similarities at the genetic level imply a common biosynthetic origin for these pathways. Here, we describe insights about rules governing this modular biosynthesis, taking advantage of the fact that nowadays five of these gene clusters have been made public (thiocoraline, triostin, SW-163 and echinomycin/quinomycin). This modularity has potential application for designing and producing novel genetic engineered derivatives, as well as for developing new chemical synthesis strategies. These would facilitate their clinical development. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Fernández, J.; Marín, L.; Álvarez-Alonso, R.; Redondo, S.; Carvajal, J.; Villamizar, G.; Villar, C.J.; Lombó, F. Biosynthetic Modularity Rules in the Bisintercalator Family of Antitumor Compounds. Mar. Drugs 2014, 12, 2668-2699.
Fernández J, Marín L, Álvarez-Alonso R, Redondo S, Carvajal J, Villamizar G, Villar CJ, Lombó F. Biosynthetic Modularity Rules in the Bisintercalator Family of Antitumor Compounds. Marine Drugs. 2014; 12(5):2668-2699.Chicago/Turabian Style
Fernández, Javier; Marín, Laura; Álvarez-Alonso, Raquel; Redondo, Saúl; Carvajal, Juan; Villamizar, Germán; Villar, Claudio J.; Lombó, Felipe. 2014. "Biosynthetic Modularity Rules in the Bisintercalator Family of Antitumor Compounds." Mar. Drugs 12, no. 5: 2668-2699.